Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare OTC:INLB NASDAQ:IONM OTCMKTS:LENSF OTCMKTS:REMI On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeINLBItem 9 Labs$0.00$0.00▼$0.10$70K0.7713.46 million shsN/AIONMAssure$0.05$0.04$0.03▼$0.55$150K185.124,148 shsN/ALENSFPresbia$0.02$0.02$0.00▼$0.19$257K5.915,650 shsN/AREMIRemedent$0.01$0.01$0.01▼$0.07$180K-0.192 shsN/AThe 10 Best AI Stocks to Own in 2025Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceINLBItem 9 Labs0.00%0.00%0.00%0.00%0.00%IONMAssure0.00%0.00%0.00%+0.42%-63.50%LENSFPresbia0.00%0.00%0.00%0.00%0.00%REMIRemedent0.00%0.00%0.00%-10.20%-83.67%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeINLBItem 9 Labs$0.00$0.00▼$0.10$70K0.7713.46 million shsN/AIONMAssure$0.05$0.04$0.03▼$0.55$150K185.124,148 shsN/ALENSFPresbia$0.02$0.02$0.00▼$0.19$257K5.915,650 shsN/AREMIRemedent$0.01$0.01$0.01▼$0.07$180K-0.192 shsN/AThe 10 Best AI Stocks to Own in 2025Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceINLBItem 9 Labs0.00%0.00%0.00%0.00%0.00%IONMAssure0.00%0.00%0.00%+0.42%-63.50%LENSFPresbia0.00%0.00%0.00%0.00%0.00%REMIRemedent0.00%0.00%0.00%-10.20%-83.67%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceINLBItem 9 Labs 0.00N/AN/AN/AIONMAssure 0.00N/AN/AN/ALENSFPresbia 0.00N/AN/AN/AREMIRemedent 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookINLBItem 9 Labs$21.76M0.00N/AN/AN/ANaNIONMAssure$149K1.01N/AN/A($41.04) per share0.00LENSFPresbiaN/AN/AN/AN/AN/AN/AREMIRemedent$990K0.18N/AN/AN/A∞Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateINLBItem 9 Labs-$31.14MN/A0.00N/AN/AN/AN/AN/AN/AIONMAssure-$26.08MN/A0.00∞N/A-25,178.32%N/A-249.78%9/25/2025 (Estimated)LENSFPresbiaN/AN/A0.00∞N/AN/AN/AN/AN/AREMIRemedent-$270K-$0.01N/A∞N/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthINLBItem 9 LabsN/AN/AN/AN/AN/AIONMAssureN/AN/AN/AN/AN/ALENSFPresbiaN/AN/AN/AN/AN/AREMIRemedentN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioINLBItem 9 LabsN/AN/AN/AIONMAssureN/A0.200.20LENSFPresbiaN/AN/AN/AREMIRemedentN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipINLBItem 9 LabsN/AIONMAssure3.33%LENSFPresbiaN/AREMIRemedentN/AInsider OwnershipCompanyInsider OwnershipINLBItem 9 Labs19.80%IONMAssure3.80%LENSFPresbia74.20%REMIRemedentN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableINLBItem 9 Labs100701.92 million562.85 millionNot OptionableIONMAssure1303.13 million3.02 millionNot OptionableLENSFPresbia2017.12 millionN/ANot OptionableREMIRemedent420.00 millionN/ANot OptionableINLB, LENSF, REMI, and IONM HeadlinesRecent News About These CompaniesEx-Chelsea striker looks like completely new person just one year after retirementAugust 28, 2024 | mirror.co.ukMTikTok star Remi Bader shares fitness transformation after slamming trolls over weight criticismMay 25, 2024 | pagesix.comPRemi Bader Shows Off Body Transformation After 'Putting Myself First': 'This Is Not About Weight or Looks'May 25, 2024 | people.comPRémi Laurent Biography & MoviesApril 29, 2024 | tribute.caTRémi Laurent Biography & MoviesApril 29, 2024 | tribute.caTREMYY Rémy Cointreau SAApril 24, 2024 | seekingalpha.comRemi LambertFebruary 29, 2024 | thesun.co.ukPeterson RemyFebruary 15, 2024 | health.usnews.comRemi MonaghanJanuary 10, 2024 | fox17online.comFremy ma and papooseDecember 6, 2023 | hiphopwired.comHRémi Bonnet Breaks Longtime Pikes Peak Ascent RecordSeptember 25, 2023 | runnersworld.comRHome and Away spoiler: Remi keeps quiet about the kissAugust 20, 2023 | digitalspy.comDRemi Wolf Returns with New Single “Prescription,” Inspired by Phone Call with Boots Riley: StreamJune 2, 2023 | yahoo.comHome and Away spoilers: Remi collapses in Salt as his injury worsensMarch 27, 2023 | metro.co.ukMLove Island star Remi Lambert claims he was assaulted by one of Jacques O'Neill's friendsMarch 22, 2023 | mirror.co.ukMRemi Matthews focuses on the present with St JohnstoneMarch 17, 2023 | irishnews.comILioness of Bourdillon: How Remi Tinubu Becomes the New Beautiful BrideMarch 7, 2023 | thisdaylive.comTRemi Bader shares what happened to her when she stopped taking OzempicFebruary 5, 2023 | today.comT‘Most female colleagues have Sugar Daddy,’ Anita Joseph replies Kunle RemiJanuary 28, 2023 | vanguardngr.comVWhere is Remi Adeleke and who is Chris Oliver from SAS: Who Dares Wins?January 25, 2023 | uk.news.yahoo.comMedia Sentiment Over Time Top HeadlinesView All Headlines3 Robotics Stocks at the Heart of the Robotics RevolutionBy Chris Markoch | August 21, 2025Is Viking’s Growth Still Worth the Premium?By Chris Markoch | August 20, 2025Patch Tuesday Highlights Microsoft’s Growing Security EdgeBy Chris Markoch | August 25, 2025Lockheed Martin: Is the Market Overlooking This Defensive Giant?By Jeffrey Neal Johnson | September 5, 2025Why CoreWeave's NVIDIA Deal Creates a Deep Moat for AI InvestorsBy Jeffrey Neal Johnson | September 17, 2025INLB, LENSF, REMI, and IONM Company DescriptionsItem 9 Labs OTC:INLBItem 9 Labs Corp. operates as a vertically integrated cannabis operator and dispensary franchisor in the United States. The company produces cannabis and cannabis-related products in various categories, such as flower; concentrates; distillates; and hardware. It offers cannabis and cannabis-derived products and technologies through licensed dispensaries to consumers in Arizona. It also operates and sells medical and adult-use cannabis dispensary franchises under the Unity Rd brand name. Item 9 Labs Corp. is headquartered in Phoenix, Arizona.Assure NASDAQ:IONM$0.05 0.00 (0.00%) As of 09/15/2025Assure Holdings Corp., through its subsidiaries, provides technical and professional intraoperative neuromonitoring surgical support services in the United States. It offers services in the areas of neurosurgery, spine, cardiovascular, orthopedic, ear, nose, throat, and other surgical procedures. The company delivers various clinical and operational services, including scheduling of the interoperative neurophysiologist and supervising practitioner, real time monitoring, patient advocacy, and billing services to support surgeons and medical facilities during invasive procedures. Assure Holdings Corp. is based in Englewood, Colorado.Presbia OTCMKTS:LENSF$0.02 0.00 (0.00%) As of 10/21/2022Presbia PLC, an ophthalmic device company, develops and markets optical lens implants for treating presbyopia. The company provides the refractive lens for patient surgeries, as well as accessories for procedures. It primarily operates in the United States, South Korea, Australia, Italy, the Netherlands, Ireland, Canada, and Germany. The company was founded in 2014 and is headquartered in Dublin, Ireland.Remedent OTCMKTS:REMI$0.0090 0.00 (0.00%) As of 09/16/2025Remedent, Inc. researches, designs, develops, manufactures, and distributes oral care and cosmetic dentistry products in the United States and internationally. It primarily provides professional veneers and teeth whitening products for professional and over-the-counter use. The company also offers River8, a prefab veneer that enables the dentist to find the right combination of teeth for a patient with minor reshaping. In addition, it provides GlamSmile veneers, which are ultra-thin claddings attached to the front of the patient's teeth. Further, the company offers SmileMe Mirror, an integrated marketing concept for the dental practice that enables dentists to offer smile consultation in approximately 10 minutes; SmileSketch, a simulation software to make a sketch of what the patient could look like; and various Treatment Pages to explain the benefits of certain treatments, as well as Condor, an intra-oral 3D scanner. Additionally, it provides dental implant solutions and treatment concepts. The company sells its products through internal sales force and third party distributors. Remedent, Inc. was incorporated in 1986 and is headquartered in Ghent, Belgium. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Nike’s Red-Hot Analyst Buzz: Is a Comeback Brewing? Broadcom Hits Record High After CEO Hock Tan AI Pay Package CrowdStrike Stock Set for Breakout as Agentic AI Demand Surges Why CoreWeave's NVIDIA Deal Creates a Deep Moat for AI Investors Resideo Technologies: Institutional Activity Signals 30% Upside This Stock Quietly Benefits From Oracle and NVIDIA’s AI Surge Rezolute Stock: FDA Fast Track Fuels 2025 Breakout Lululemon’s Sell-Off Looks Overdone: A Contrarian Case Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
